Search Results

Colon Cancer Immunotherapy Search Results

Your search returned 3 record(s).
Page 1 of 1

Sort By:

Please visit our sponsors.

Important: Access to this information is subject to the full Cancer Monthly User Agreement .

We urge you to read this User Agreement. Below are some excerpts from this Agreement. These excerpts are provided for your convenience only and do not replace the full User Agreement:

Cancer Monthly does not provide medical or any other health care advice, diagnosis or treatment.
Cancer Monthly is provided for informational purposes only and is not a substitute for professional medical advice, examination, diagnosis or treatment.
You should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to existing treatment.
You should not delay in seeking or disregard medical advice based on information in Cancer Monthly or the information below.
All the information available on the Cancer Monthly website including the information below is designed to be shared with your physician or other qualified healthcare professional
Medical information changes rapidly and while Cancer Monthly makes efforts to update its content, some information may be out of date.
No information contained in Cancer Monthly including the information below, should be used to diagnose, treat, cure or prevent any disease without the supervision of a medical doctor.

Again, your access to the information below is subject to the entire User Agreement.

	Survival:	Patients:	Toxicity:	Treatment:	Hospital:	Country:	Date:
1	52.9 months	colorectal (metastatic)	2	Biologic therapy Immunotherapy	Ospedale Civile di Avezzano	Italy	9/2006
Treatment Details: Patients: This phase II study compared two groups of patients. The group receiving the study treatment consisted of 40 people, 26 men and 14 women. The other group, historical controls, co

2	N/R	Advanced or recurrent colorectal cancer	2	Immunotherapy	Sapporo Medical University School of Medicine	Japan	6/2004
Treatment Details: Patients: This Phase I study involved 15 patients with advanced or recurrent colorectal cancer. Treatment: The treatment (immunotherapy) consisted of a survivin-2B peptide vaccination.

3	?	Stage III colon cancer	5	Chemotherapy Immunotherapy Surgery	Vrije Universiteit Medical Center	Netherlands	4/2002
Treatment Details: Patients: This Phase II study involved 56 patients with colon cancer (stage III). Treatment: Treatment consisted of surgery followed autologous tumour cell vaccinations and the chemothera

Page 1 of 1\|

DISCLAIMER: The following is a summary of some of the terms & conditions for accessing the information on this website. It is provided for convenience only. For the full terms & conditions please click here. This website should not be used for diagnosing or treating a health problem or disease and it is not a substitute for professional medical advice, examination, diagnosis or treatment. You should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to an existing treatment. You should not delay in seeking or disregard medical advice based on information on this website. This website provides links to other websites for convenience only. Cancer Monthly is not responsible for the availability or content of these external websites, nor does Cancer Monthly endorse, warrant or guarantee the products, services or information described or offered at these other websites.